Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted R Mikuls

Showing results (281-290 of 351) with videos related to

Pageof 36
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
International Journal of Molecular Sciences|December 20, 2018
Novel Antioxidant Properties of DoxycyclineDahn L Clemens, Michael J Duryee, Cleofes Sarmiento, et al.
ACS Nano|December 18, 2013
Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomesLingdong Quan, Yijia Zhang, Bart J Crielaard, et al.
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Rheumatology (Oxford, England)|March 24, 2022
Elevations in adipocytokines and mortality in rheumatoid arthritisJoshua F Baker, Bryant R England, Michael D George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritisTed R Mikuls, Justin O Endo, Susan E Puumala, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Seminars in Arthritis and Rheumatism|August 9, 2025
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trialSamantha Kohn, Harlan Sayles, Lindsay N Helget, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2020
Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid ArthritisAriadne V Ebel, Gabrielle Lutt, Jill A Poole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid ArthritisTate M Johnson, Halie Frideres, Punyasha Roul, et al.
Pageof 36

Showing results (281-290 of 351) with videos related to

Sort By:
Pageof 36
Arthritis & Rheumatology (Hoboken, N.J.)|August 4, 2021
American College of Rheumatology Guidance for COVID-19 Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: Version 3Jeffrey R Curtis, Sindhu R Johnson, Donald D Anthony, et al.
International Journal of Molecular Sciences|December 20, 2018
Novel Antioxidant Properties of DoxycyclineDahn L Clemens, Michael J Duryee, Cleofes Sarmiento, et al.
ACS Nano|December 18, 2013
Nanomedicines for inflammatory arthritis: head-to-head comparison of glucocorticoid-containing polymers, micelles, and liposomesLingdong Quan, Yijia Zhang, Bart J Crielaard, et al.
International Immunopharmacology|May 2, 2021
Associations of serum cytokines and chemokines with the risk of incident cancer in a prospective rheumatoid arthritis cohortBryant R England, Megan Campany, Harlan Sayles, et al.
Rheumatology (Oxford, England)|March 24, 2022
Elevations in adipocytokines and mortality in rheumatoid arthritisJoshua F Baker, Bryant R England, Michael D George, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2006
Prospective study of survival outcomes in Non-Hodgkin's lymphoma patients with rheumatoid arthritisTed R Mikuls, Justin O Endo, Susan E Puumala, et al.
Seminars in Arthritis and Rheumatism|April 25, 2025
Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user studyHalie Frideres, Christopher S Wichman, Jianghu Dong, et al.
Seminars in Arthritis and Rheumatism|August 9, 2025
Real-world persistence of urate-lowering therapy following a treat-to-target intervention: A two-year follow-up analysis of the STOP gout trialSamantha Kohn, Harlan Sayles, Lindsay N Helget, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 15, 2020
Association of Agricultural, Occupational, and Military Inhalants With Autoantibodies and Disease Features in US Veterans With Rheumatoid ArthritisAriadne V Ebel, Gabrielle Lutt, Jill A Poole, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|February 9, 2026
Performance of the Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Calculator in Rheumatoid ArthritisTate M Johnson, Halie Frideres, Punyasha Roul, et al.
Pageof 36